Australian Regulators Approve Owlet’s Dream Sock

Owlet Inc.’s has secured Australian Therapeutic Goods Administration (TGA) certification for its Dream Sock, a wearable smart baby monitor.

“TGA certification of Dream Sock marks an important step forward in our global expansion, bringing more families worldwide access to the latest pediatric health monitoring technology,” Owlet President Jonathan Harris said. “For parents in these markets, certification means they will soon have access to a trusted, medically-certified tool to support their baby’s health and well-being.”

Dream Sock is designed for healthy infants between 0-18 months or 2.5 kg to 13.6 kg. that tracks key health indicators such as pulse rate, oxygen level, and sleep patterns. The connected Owlet Dream App displays readings in real-time, and both the Dream App and the included Base Station provide notifications if measurements fall outside preset ranges.

Having monitored more than 2 million babies globally, Owlet is expanding access to its newly certified medical device to give more families peace of mind. Dream Sock is expected to be available for purchase later this year in Australia and New Zealand through the company’s local website and retail partners, including Baby Bunting.

Owlet’s digital health infant monitoring platform strives to transform the parenting journey. A small-cap healthcare growth equity, the company offers U.S. Food and Drug Administration-authorized medical and consumer pediatric wearables and an integrated HD visual and audio camera that provide real-time data and insights to parents who safeguard health, optimize wellness, and ensure peaceful sleep for their children.

Since 2012, more than 2 million parents worldwide have used Owlet’s platform, contributing to one of the largest collections of consumer infant health and sleep data. The company continues to develop software and digital data solutions to bridge the current healthcare gap between hospital and home and bring new insights to parents and caregivers globally.